Antares Pharma reported $45.13M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Adma Biologics ADMA:US $ 34.41M 8M
Aerie Pharmaceuticals AERI:US $ 61.85M 18.11M
Ani Pharmaceuticals ANIP:US $ 15.25M 9.01M
Atrion ATRI:US 23.66M 6.59M
Becton, Dickinson and BDX:US $ 2283M 870M
Biodelivery Sciences International BDSI:US 100.71M 19.14M
Cara Therapeutics CARA:US $ 22.99M 656K
Cerus CERS:US $ 78.46M 19.43M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Endo International Ordinary Shares ENDP:US $ 1568.66M 23.49M
Horizon Pharma HZNP:US $ 1068.55M 256.23M
Jazz Pharmaceuticals JAZZ:US 1000 0
Meridian Bioscience VIVO:US $ 49.77M 48.75M
Orasure Technologies OSUR:US $ 134.96M 23.16M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Revance Therapeutics RVNC:US $ 127.18M 40.46M
Rockwell Medical RMTI:US $ 23.39M 8.99M
Sientra SIEN:US $ 66.13M 16.29M
Staar Surgical STAA:US $ 196.25M 23.16M
Supernus Pharmaceuticals SUPN:US $ 215.28M 8.49M
Teva Pharmaceutical TEVA:IT 2.04B 391M
Teva Pharmaceutical Industries TEVA:US $ 2045M 391M
Utah Medical Products UTMD:US $ 64.32M 8.29M
Zogenix ZGNX:US $ 106.14M 28.81M